-
Searching the Blood for Signs of Altered Immunity
The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
When Cancer’s Spread Is Limited
People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
-
Forward Look
What’s Next? Spring 2021A new way to evaluate patients with prostate cancer.
by Christina Bennett
-
More Ways to Treat Advanced Kidney Cancer
New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.
by Kendall K. Morgan
-
Forward Look
New Therapies for Metastatic Lung CancerSeveral targeted drugs were approved in 2020 to treat the most common type of lung cancer.
by Ashley P. Taylor
-
Survivor Profile
A Return to CarnivalWith a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents' native Trinidad to celebrate the Caribbean festival.
by Lindsey Konkel
-
From the Editor-in-Chief
Cancer in Adolescents and Young AdultsPatients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.
by William G. Nelson, MD, PhD
-
Forward Look
A Strategy to WatchSome rectal cancer patients may safely avoid life-altering surgery.
by Kristine Conner
-
Sound Advice
Spring 2021vol 11 | issue 01
Maintaining relationships through cancer, feeling unappreciated as a caregiver, and finding information that's relevant to young people with cancer. -
Healthy Habits
Daily DoseAspirin can be taken daily to reduce the risk of colorectal cancer, but it's not recommended for everyone.
by Bradley Jones
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon